The study also demonstrated a correlation between PARL or STARD7 expression and cancer cell resistance to the ferroptosis inhibitor protein GPX4, suggesting that targeting PARL or STARD7 could be a potential strategy to disrupt ferroptosis and provide novel approaches for anticancer therapies [140]. The gene discussed is GPX4; the disease is cancer.